DOT Logo

U.S. Department
of Transportation
Federal Transit
Administration
Office of Safety and Security

FTA Drug And Alcohol Regulation Updates

Spring 2004

Issue 27

Introduction....

The Federal Transit Administration (FTA) published its revised rule on prohibited drug use and the prevention of alcohol misuse (49 CFR Part 655) on August 1, 2001. The FTA published the revised Implementation Guidelines for Drug and Alcohol Regulations in Mass Transit to provide a comprehensive overview of the regulations.
Since the Guidelines were published, there have been numerous amendments, interpretations, and clarifications to the Drug and Alcohol testing procedures and program requirements.
This publication is being provided to update the Guidelines and inform your transit system of these changes. This Update is the twenty-seventh in a series.

 

 

 

Inside....

ODAPC Director Appointed

On May 17, John A. Bobo, Jr. was appointed the U.S. DOT’s Director of the Office of Drug and Alcohol Policy and Compliance (ODAPC). The ODAPC’s mission is to enhance public safety within U.S. transportation industries by ensuring that DOT’s drug and alcohol policies are implemented in a consistent, fair and efficient manner. The Office provides program review, compliance evaluation, and issues consistent guidance material for FTA and the other DOT operating administrations.

Mr. Bobo previously served as the Director of the National Law Center at the American Prosecutors Research Institute (APRI), a non-profit organization that provides research, training and technical assistance to prosecutors, judges, officers, and others in the law enforcement community. In 2002, Mr. Bobo assisted the White House’s Office of National Drug Control Policy, in forming and releasing its drugged driver policy statement.
Mr. Bobo also served as an Assistant District Attorney in the District Attorney General’s Office in Maryville, TN where his primary area of responsibility was serving as liaison to the 5th Judicial Drug Task Force. In Chattanooga, TN he prosecuted drug-related murder cases and narcotics cases. He served as a special vehicular homicide/impaired-driving prosecutor and served on the Board of Directors of a local alcohol and drug rehabilitation facility.
In his new position, Mr. Bobo can be reached at (202) 366-3784 or john.bobo@ost.dot.gov.

Contact Us About Future Editions!

The electronic publication and distribution of future editions of this newsletter will be phased in over the next six months. This article is the second of three announcements that will be made before the electronic publication process goes into full effect. This edition and the Summer 2004 edition scheduled for publication in August will be distributed both electronically and by mail. The Fall 2004 edition scheduled for publication in November will be distributed via the Internet to those who have provided email addresses.
FTA Drug and Alcohol Regulation Updates NewsletterHard copies will be mailed only to those individuals who have requested to continue receipt of the newsletter via the U.S. Postal Service.

Persons that have failed to contact us to confirm their continued interest or to request their preferred method of distribution will be purged from the database. At the time of this newsletter publication, nearly fourteen percent of the individuals on the database had already contacted us with their email addresses.

To continue to receive future editions of the newsletter, please contact the editor at rlsasc@mindspring.com, call (937) 299-5007, or fax (937) 299-1055.
 

FTA Program Represented at CTAA Expo

The FTA Drug and Alcohol Program will once again have an exhibit at the CTAA Expo to be held in Seattle on June 16-17. FTA representatives will be there to distribute resource materials including copies of the Implementation Guidelines, Best Practices Manual and the Prescription and Over-the-Counter Medications Toolkit. They will be available to answer questions and demonstrate the FTA Office of Safety and Security web site including the FTA Drug and Alcohol Discussion Forum. They will be in Booth 113.

[Next Page]